Clinical Trial Update: Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of a modified release cefpodoxime formulation for acute sinusitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis
• Sinusitis

Drugs mentioned

• Cefpodoxime (cefpodoxime)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: Sinusitis, Sinusitis, Acute | Phase 3 | Status: UNKNOWN